In support of miR-17-5p’s tumor-suppressive role, recent bioinformatics and in vitro analysis revealed that levels of miR-17-5p are decreased in triple negative breast cancer cells resulting increase in CCND1 (cyclin D1) levels which is reason for uncontrolled proliferation. This evidence concerns the gene CCND1 and neoplasm.